Caribou Biosciences (CRBU) Leases: 2022-2025
Historic Leases for Caribou Biosciences (CRBU) over the last 4 years, with Sep 2025 value amounting to $16.0 million.
- Caribou Biosciences' Leases fell 21.91% to $16.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $16.0 million, marking a year-over-year decrease of 21.91%. This contributed to the annual value of $20.0 million for FY2024, which is 9.80% down from last year.
- Per Caribou Biosciences' latest filing, its Leases stood at $16.0 million for Q3 2025, which was down 2.78% from $16.5 million recorded in Q2 2025.
- Caribou Biosciences' 5-year Leases high stood at $25.7 million for Q1 2022, and its period low was $16.0 million during Q3 2025.
- Moreover, its 3-year median value for Leases was $21.1 million (2024), whereas its average is $20.6 million.
- Data for Caribou Biosciences' Leases shows a maximum YoY dropped of 22.11% (in 2025) over the last 5 years.
- Quarterly analysis of 4 years shows Caribou Biosciences' Leases stood at $24.2 million in 2022, then dropped by 8.45% to $22.2 million in 2023, then declined by 9.80% to $20.0 million in 2024, then decreased by 21.91% to $16.0 million in 2025.
- Its last three reported values are $16.0 million in Q3 2025, $16.5 million for Q2 2025, and $19.5 million during Q1 2025.